["{\n\"step_by_step_thinking\": \"The provided documents do not mention Natalizumab. Therefore, we cannot conclude whether it improves the disease course of secondary progressive multiple sclerosis based on these documents. The question is outside the scope of the provided information.\",\n\"answer_choice\": \"B\"\n}"]